Atsushi Horiike

6.4k total citations
107 papers, 2.1k citations indexed

About

Atsushi Horiike is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Atsushi Horiike has authored 107 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 78 papers in Pulmonary and Respiratory Medicine and 23 papers in Molecular Biology. Recurrent topics in Atsushi Horiike's work include Lung Cancer Treatments and Mutations (70 papers), Lung Cancer Research Studies (42 papers) and Lung Cancer Diagnosis and Treatment (29 papers). Atsushi Horiike is often cited by papers focused on Lung Cancer Treatments and Mutations (70 papers), Lung Cancer Research Studies (42 papers) and Lung Cancer Diagnosis and Treatment (29 papers). Atsushi Horiike collaborates with scholars based in Japan, United States and United Kingdom. Atsushi Horiike's co-authors include Makoto Nishio, Noriko Yanagitani, Fumiyoshi Ohyanagi, Noboru Yamamoto, Haruyasu Murakami, Satoru Kitazono, Takeshi Horai, Tomohide Tamura, Yuichi Ishikawa and Yasuhide Yamada and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Atsushi Horiike

99 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atsushi Horiike Japan	28	1.3k	1.3k	604	391	152	107	2.1k
Takehito Shukuya Japan	29	1.5k 1.2×	1.4k 1.1×	610 1.0×	438 1.1×	148 1.0×	130	2.5k
Giulia Pasello Italy	23	1.1k 0.8×	1.1k 0.8×	510 0.8×	349 0.9×	125 0.8×	165	2.0k
Francesco Facchinetti Italy	25	1.2k 0.9×	1.1k 0.9×	827 1.4×	386 1.0×	176 1.2×	79	2.1k
Puyuan Xing China	22	1.0k 0.8×	1.2k 0.9×	461 0.8×	295 0.8×	122 0.8×	149	1.7k
Leslie B. Lee United States	13	988 0.7×	790 0.6×	1.0k 1.7×	325 0.8×	196 1.3×	13	2.3k
Tinya J. Abrams United States	12	824 0.6×	835 0.6×	936 1.5×	322 0.8×	135 0.9×	17	2.1k
Toshi Menju Japan	23	966 0.7×	653 0.5×	642 1.1×	386 1.0×	174 1.1×	113	2.0k
Tak Yun South Korea	24	1.3k 1.0×	1.4k 1.0×	598 1.0×	480 1.2×	277 1.8×	81	2.3k
Toshiyuki Kozuki Japan	25	1.8k 1.4×	2.0k 1.5×	725 1.2×	299 0.8×	122 0.8×	113	3.0k
Panos Fidias United States	25	1.8k 1.4×	1.7k 1.3×	925 1.5×	276 0.7×	139 0.9×	58	3.0k

Countries citing papers authored by Atsushi Horiike

Since Specialization

Citations

This map shows the geographic impact of Atsushi Horiike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Horiike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Horiike more than expected).

Fields of papers citing papers by Atsushi Horiike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Horiike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Horiike. The network helps show where Atsushi Horiike may publish in the future.

Co-authorship network of co-authors of Atsushi Horiike

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Horiike. A scholar is included among the top collaborators of Atsushi Horiike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Horiike. Atsushi Horiike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okumura, Meinoshin, Kiminori Fujimoto, Nobuharu Hanaoka, et al.. (2025). Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations. Respiratory Investigation. 63(6). 1115–1119.

Kusumoto, Sojiro, et al.. (2024). Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study. Thoracic Cancer. 15(28). 2049–2060. 2 indexed citations

Levy, Benjamin, Luis Paz‐Ares, Wu‐Chou Su, et al.. (2024). Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC): Subgroup analysis from TROPION-Lung02.. Journal of Clinical Oncology. 42(16_suppl). 8617–8617. 5 indexed citations

Ohkuma, Ryotaro, Katsuaki Ieguchi, Makoto Watanabe, et al.. (2021). Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies. Biomedicines. 9(12). 1929–1929. 24 indexed citations

Yanagitani, Noriko, Ken Uchibori, Sumie Koike, et al.. (2020). Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms. Cancer Science. 111(3). 932–939. 41 indexed citations

Okuma, Yusuke, Yasushi Goto, Fumiyoshi Ohyanagi, et al.. (2020). Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma. Cancer Medicine. 9(20). 7418–7427. 14 indexed citations

Yanagitani, Noriko, Kanako Suga, Takahiro Yoshizawa, et al.. (2020). A Novel System to Detect Circulating Tumor Cells Using Two Different Size-selective Microfilters. Anticancer Research. 40(10). 5577–5582. 4 indexed citations

Fukuda, Koji, Shinji Takeuchi, Sachiko Arai, et al.. (2019). Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status. Cancer Research. 79(7). 1658–1670. 79 indexed citations

Yoshizawa, Takahiro, Ryo Ariyasu, Junji Koyama, et al.. (2019). Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody. Lung Cancer. 133. 4–9. 5 indexed citations

10.

Okada, Koutaroh, Mitsugu Araki, Biao Ma, et al.. (2019). Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance. EBioMedicine. 41. 105–119. 87 indexed citations

11.

Hasegawa, Tsukasa, Noriko Yanagitani, Hirofumi Utsumi, et al.. (2019). Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer. Anticancer Research. 39(12). 6851–6857. 27 indexed citations

12.

Seto, Takashi, Koichi Azuma, Takeharu Yamanaka, et al.. (2019). Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: COMPASS (WJOG5610L). Journal of Clinical Oncology. 38(8). 793–803. 25 indexed citations

13.

Shiraishi, Yoshimasa, Haruko Daga, Satoshi Ikeda, et al.. (2019). A multicenter, open label, randomized phase III study of atezolizumab with platinum-pemetrexed and with or without bevacizumab for patients with advanced nonsquamous non-small cell lung cancer (WJOG11218L APPLE Study).. Journal of Clinical Oncology. 37(15_suppl). TPS9125–TPS9125. 3 indexed citations

14.

Kawano, Yuko, T. Sasaki, Hiroyuki Yamaguchi, et al.. (2018). Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer. Lung Cancer. 125. 136–141. 16 indexed citations

15.

Nokihara, Hiroshi, Makoto Nishio, Noboru Yamamoto, et al.. (2018). Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 20(3). e317–e328. 29 indexed citations

16.

Nakamura, Atsushi, Hibiki Udagawa, Shingo Matsumoto, et al.. (2017). Prevalence of NTRK gene fusions in a large cohort of Japanese patients with lung cancer. Annals of Oncology. 28. x126–x126. 3 indexed citations

17.

Nishio, Makoto, Atsushi Horiike, Hiroshi Nokihara, et al.. (2015). Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer. Investigational New Drugs. 33(3). 632–640. 13 indexed citations

18.

NISHIO, MAKI, Takashi Takahashi, Atsushi Horiike, et al.. (2013). A Feasibility Study of Carboplatin Plus Irinotecan Treatment for Elderly Patients with Extensive Disease Small-cell Lung Cancer. Japanese Journal of Clinical Oncology. 44(2). 116–121. 6 indexed citations

19.

Nishio, Makoto, Takeharu Yamanaka, Kazuko Matsumoto, et al.. (2011). Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma. Journal of Thoracic Oncology. 6(11). 1889–1894. 5 indexed citations

20.

Takahashi, Toshiaki, Fumiyoshi Ohyanagi, Atsushi Horiike, et al.. (2007). P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S658–S658. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact